Skip to content
Tenfell
Awarded contract
Published 21 May 2026

Commercialising Scientific Advice for MHRA

Medicines and Healthcare products Regulatory Agency · United Kingdom

Key facts

Contract value
£98,000
Awarded
18 May 2026
Contract starts
14 Jun 2026
Contract ends
21 Aug 2026
Procedure
Below threshold - without competition
Buyer type
Central government

Awarded to

SupplierValue
DELOITTE LLP£98,000

Description

The Medicines and Healthcare Products Regulatory Agency requires consultancy to support the MHRA in responding to increasing demand, improving service quality and predictability, and ensuring the Scientific Advice offer remains competitive, sustainable, and aligned with the MHRA 2030 Strategy. The Deliverables are as follows: • Description of MHRA's unique strengths and market context; 5-10 critical hypotheses regarding potential demand and operational requirements for the MHRA to commercialise scientific advice (e.g. clinical trial advice, licensing advice, post marketing surveillance) • Synthesis and summary of 10-20 industry, expert and MHRA interviews and secondary research to define demand, likely services and their range of price points, and operational requirements for the MHRA to deliver Commercial Scientific Advice • Summary board document (presentation slide deck) that outlines core offering that is compelling, sustainable, and maintains MHRA's independent regulatory scrutiny; high level roadmap of next steps and value to MHRA.

Categories (CPV)

Similar open tenders

About Medicines and Healthcare products Regulatory Agency

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Find a Tender (Open Government Licence v3.0). Always read the original notice before responding.